Skip to content

Clinical trials

Prostatic Hyperplasia trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: Greece Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20061
20071
20093
20103
20131
20191
20201
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
GlaxoSmithKline4
Elpen Pharmaceutical Co. Inc.2
G.Gennimatas General Hospital1
Institute for Monitoring of Urogenital Diseases1
Pfizer1
Sanofi1
Société Internationale d'Urologie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia16
Lower Urinary Tract Symptoms3
Erectile Dysfunction1
Inflammation1
Prostatic Neoplasms1
Urinary Retention1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.